Pre-clinical screening of immunomodulatory compounds using the parent-into-F1 model()

Ítems similars

• Advances in lupus stemming from the parent-into-F1 model
  per: Via, Charles S.
  Publicat: (2010)
• Implications of the parent-into-F1 model for human lupus pathogenesis: roles for cytotoxic T lymphocytes and viral pathogens
  per: Via, Charles S.
  Publicat: (2010)
• The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation
  per: Puliaev, R.A., et al.
  Publicat: (2005)
• Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: Evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus
  per: VIA, CHARLES S., et al.
  Publicat: (2010)
• Screening of Chorioamnionitis Using Volatile Organic Compound Detection in Exhaled Breath: A Pre-clinical Proof of Concept Study
  per: Ophelders, Daan R. M. G., et al.
  Publicat: (2021)